OTCMKTS:IMMD (IMMD) (IMMD) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free IMMD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.21▼$0.2450-Day Range N/A52-Week Range$0.18▼$0.54Volume17,717 shsAverage Volume88,094 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (IMMD) alerts: Email Address Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit About (IMMD) Stock (OTCMKTS:IMMD)LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.Read More Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit IMMD Stock News HeadlinesFebruary 29, 2024 | msn.comPisces: Monthly horoscope MarchFebruary 23, 2024 | msn.comSuspects Sought In Hoboken Carjacking; Police Release PhotosMay 4, 2024 | Behind the Markets (Ad)Investors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.February 16, 2024 | msn.comPrice of public EV charging soars as filling up petrol cars becomes cheaperJanuary 31, 2024 | msn.comPisces: Monthly horoscope JanuaryJanuary 1, 2024 | msn.comCapricorn: Monthly horoscope JanuaryDecember 20, 2023 | msn.comHong Kong removes restriction for international students doing part-time jobsOctober 24, 2023 | msn.comUAE Calls for Immediate Ceasefire and Humanitarian Aid in GazaMay 4, 2024 | Behind the Markets (Ad)Investors Alert: The Next Big Thing in Weight LossUBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year.October 17, 2023 | msn.comValue his guidance for further development of bilateral relationship: writes S Jaishankar on X after meeting Vietnamese Prime Minister Pham Minh ChinhOctober 8, 2023 | msn.comHongkongers in Israel urged to follow official instructions as top envoy in city warns of escalating violenceSeptember 1, 2023 | msn.comCapricorn: Monthly horoscope SeptemberAugust 29, 2023 | msn.comUS photography professor who covered 2019 protests says Hong Kong denied him entry, suspects he is ‘on a list’August 1, 2023 | msn.comCapricorn: Monthly horoscope AugustJuly 23, 2023 | msn.comTwo Chinese Nationals Arrested In Bihar; Second Attempt To Enter In India Via Nepal In Less Than A MonthJuly 23, 2023 | msn.comTwo Chinese Men Arrested for Trying to Illegally Cross India-Nepal Border in BiharJuly 18, 2023 | msn.comImmigration nabs foreigner selling fake documentsJuly 3, 2023 | msn.comJapanese journalist who covered the 2019 protests denied entry to Hong Kong – reportsJuly 1, 2023 | msn.comCapricorn: Monthly horoscope JulyJune 1, 2023 | msn.comCapricorn: Monthly horoscope JuneMay 1, 2023 | msn.comCapricorn: Monthly horoscope MayApril 11, 2023 | marketwatch.comDetailed Analysis of Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market Forecast 2023 to 2027April 1, 2023 | msn.comCapricorn: Monthly horoscope AprilMarch 31, 2023 | msn.comLewis Hamilton expects third row to be Mercedes’ qualifying ceiling on SaturdayMarch 30, 2023 | msn.com9 million people expected to pass through Hong Kong’s border control points over Ching Ming Festival, Easter as authorities estimate post-Covid visitor surgeMarch 7, 2023 | msn.comWhy InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higherMarch 6, 2023 | msn.com49ers TE George Kittle again campaigns for two bye weeksSee More Headlines Receive IMMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (IMMD) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & Botanicals Sub-IndustryN/A Current SymbolOTCMKTS:IMMD CUSIPN/A CIKN/A Webwww.immudyne.com Phone(866) 351-5907FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesJustin SchreiberChairman & Chief Executive OfficerAlexander MironovPresidentBrad RobertsChief Operating OfficerMarc BenathenChief Financial OfficerJoseph V. DiTrolioIndependent Director & Chief Medical Officer-USKey CompetitorsDiamond WellnessOTCMKTS:POTNEntia BiosciencesOTCMKTS:ERGOJinhua Marine BiologicalOTCMKTS:JNMBPacificHealth LaboratoriesOTCMKTS:PHLIRock Creek PharmaceuticalsOTCMKTS:RCPIQView All Competitors IMMD Stock Analysis - Frequently Asked Questions What other stocks do shareholders of (IMMD) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (IMMD) investors own include Vuzix (VUZI), Marijuana Company of America (MCOA), DICK'S Sporting Goods (DKS), Cara Therapeutics (CARA), Oracle (ORCL), Amarin (AMRN), Yamana Gold (AUY), BioTelemetry (BEAT) and Bellerophon Therapeutics (BLPH). This page (OTCMKTS:IMMD) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (IMMD) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
